Integra Lifesciences Holdings (IART) Return on Sales (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales declined to 0.0% in Q1 2026, from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2022 to a low of 0.01% in Q2 2025.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales changed 0 bps in 2022 and fell 1 bps in 2025, its largest moves.
• Tracing IART's Return on Sales over 5 years: stood at 0.0% in 2022, then sank by 62 bps to 0.0% in 2023, then decreased by 12 bps to 0.0% in 2024, then slumped by 109 bps to 0.0% in 2025, then tumbled by 201 bps to 0.0% in 2026.
• Business Quant data shows IART's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.